Veterinary Stents Market Size & Share 2026-2035

Veterinary Stents Market Size

The global veterinary stents market was valued at USD 47.5 million in 2025. The market size is estimated to grow from USD 50.2 million in 2026 to USD 92 million in 2035, growing at a CAGR of 7%, as per the latest report published by Global Market Insights Inc.

Veterinary stents are commonly used in veterinary medicine to manage tracheal collapse, urethral obstructions, esophageal strictures, and vascular anomalies in animals. With the growing emphasis on pet health and well-being, there is an increasing demand for advanced medical interventions, including stents. This demand is further supported by the rising number of pets, with the 2024 Global Pet Parent Study reporting nearly 1 billion pets worldwide. Additionally, the growing humanization of pets, which increases pet owners' interest in sophisticated pet care, further contributes to the adoption of stenting procedures, particularly in developed economies with advanced veterinary care.
 

In addition, technological advances have significantly driven the growth of this market. The introduction of minimally invasive techniques, newer stent materials including nitinol and polymers, and improvements in endoscopic and fluoroscopic placement techniques has resulted in increased effectiveness and widespread acceptance of veterinary stents. These innovations have led to improved patient outcomes, shorter recovery times, and a minimal risk of complications, making stents a preferred option for both veterinarians and pet owners.
 

Veterinary stents are implants used in animals that suffer from obstructions or narrowing of an anatomical structure due to various diseases, traumatic injuries, or congenital malformations. These tubular devices, constructed from metal alloys such as nitinol or polymer-based compounds, are inserted into the airways, blood vessels, and other tubular structures to restore normal function. Key players in this market include Infiniti Medical, Dextronix Animal Health, TaeWoong Medical, Create Medic, AbtVet (Stening Group), M.I. Tech, and UltraVet Medical Devices. These players are constantly involved in product development, technological advancements, and strategic collaborations to strengthen their market presence and expand their product portfolios.
 

Between 2022 and 2024, the market grew from USD 40.8 million to USD 45 million, reflecting the steady adoption of advanced interventional procedures in veterinary medicine. In addition, the consolidation of veterinary clinics and hospitals further supported the market growth. Veterinary chains and corporate entities are purchasing independent clinics, leading to increased spending on advanced diagnostic and treatment technologies such as stenting, which in turn supports the growth of the market. Furthermore, the adoption of pet insurance has significantly helped cover these costs, increasing the financial accessibility of stenting procedures for a wider population.

Veterinary Stents Market Trends

• The increasing prevalence of respiratory and urological disorders in animals is one of the major trends driving the global veterinary stents industry.
   
• Respiratory disorders, particularly tracheal collapse, commonly affect small dog breeds, which greatly drives the demand for tracheal stents. Tracheal collapse is a progressive, chronic disease that frequently affects toy and small-breed dogs, such as Yorkshire Terriers, Pomeranians, and Chihuahuas.
   
• Traditional treatment options, such as the use of corticosteroids and bronchodilators, offer temporary relief, whereas tracheal stents help in maintaining airway patency, offering a long-term treatment option. Thus, as tracheal stents gain recognition as an effective alternative to invasive surgeries, their adoption among veterinarians and pet owners is increasing.
   
• Additionally, urinary tract obstruction is a life-threatening condition that commonly affects male cats and ruminants, such as goats and cattle.
   
• For instance, as per an article published by Today’s Veterinary Practice, the feline urethral obstruction incidence was estimated to be between 1.5% and 9%, indicating a growing need for effective and less invasive interventions, such as urethral stenting.
   
• In livestock, the prevalence of urethral obstruction is also significant, especially in younger male ruminants, where studies by the Indian Council of Agricultural Research (ICAR) estimate that 60% of cases occur in such animals. Additionally, in cattle, urethral obstruction occurs in 18.69% of cases and predominantly affects male cattle.
   
• With these rising cases of urinary obstruction, there is an increased adoption of urethral stents, which serve as a minimally invasive alternative to traditional interventions such as urethrotomy or perineal urethrostomy surgery. These urethral stents reduce surgical risks as well as recovery times and restore normal urinary function, making them an ideal option in veterinary practice.
   
• Thus, as the incidence of chronic diseases, including respiratory and urological disorders in both companion and livestock animals grows, the need for veterinary stents is expected to grow over the coming years.
   
• Moreover, with advances in veterinary medicine, there is an improved diagnosis and treatment of such conditions, which further drives the demand for less invasive solutions like tracheal and urethral stents.
   

Veterinary Stents Market Analysis

Based on the product, the veterinary stents market is segmented into airway stents, vascular stents, urethral stents, and other stents. The airway stents segment dominated the global market and was valued at USD 18.7 million in 2025.
 

• The growth of this segment is largely driven by the rising prevalence of tracheal collapse in small dog breeds. Tracheal collapse is a chronic and progressive condition causing narrowing of the airways and resulting in severe respiratory distress. Thus, the severity of this condition necessitates airway stenting.
   
• Adoption of airway stents has been facilitated by the changing pet owner and veterinarian preference toward minimally invasive veterinary procedures, as well as innovations in stent materials like self-expanding nitinol and biodegradable polymers.
   
• Furthermore, the development of endoscopic and fluoroscopic-guided methods for stent placement has increased precision, decreased complication rates, and improved overall success rates. Owing to these advancements, airway stents have become more effective and accessible, leading to their widespread adoption in specialty veterinary hospitals and emergency clinics.
   
• On the other hand, the vascular stents segment is expected to witness growth at a CAGR of 7.2% over the analysis period, driven by the increasing use of minimally invasive interventional procedures for treating vascular abnormalities in companion animals.

Based on the animal, the veterinary stents market is categorized into dogs, cats, and other animals. The dogs segment accounted for a significant market share of 60.6% in 2025.
 

• The increase in cases of stent-requiring conditions in canines, such as urethral obstructions, tracheal collapse, and vascular abnormalities, contributes to the strong growth of this segment.
   
• Small and toy breeds, such as the Yorkshire Terrier, Chihuahua, and Pomeranian, are more susceptible to tracheal collapse, which requires airway stenting. Similarly, large-breed dogs commonly have vascular and urethral obstructions, greatly augmenting the demand for vascular and urethral stents.
   
• Due to its high success rate and low recovery times in contrast to traditional surgery, stenting is one of the preferred treatment options. Thus, as veterinary care advances and minimally invasive procedures gain traction, the demand for veterinary stents is expected to rise in small animals, particularly dogs.
   
• Additionally, the significant global dog population has further contributed to the dominance of the dog segment in the veterinary stents market. Approximately 30% of global households own a dog, which means there are roughly between 700 million and 1 billion dogs. The U.S. is also the leader in pet dogs, with 90 million, making it an important market for advanced veterinary stents.
   

Based on the application, the veterinary stents market is classified into airway collapse, vascular obstructions, urinary tract obstructions, and other applications. The airway collapse segment was valued at USD 19.8 million in 2025 and is poised to grow at 7.1% CAGR over the analysis period.
 

• The growth of the segment can be attributed to the increasing cases of tracheal and bronchial collapse in companion animals. Airway collapse is a progressive, chronic disease of the respiratory system that results in extreme difficulty in breathing, incessant coughing, and other critical complications.
   
• With advancements in veterinary medicine, there is an increase in the adoption of tracheal stenting as it is a preferred, less invasive option than surgery. It significantly reduces recovery time and the associated risks of the procedure.
   
• There has been greater adoption of nitinol self-expanding stents and biodegradable stents. Also, improved fluoroscopic and endoscopic placement techniques have enhanced clinical success rates. These factors have made airway stents an important part of veterinary medicine.
   

Based on the material, the veterinary stents market is divided into nitinol and biodegradable polymer. The nitinol segment dominated the market and is expected to grow at 6.7% CAGR over the analysis period. On the other hand, the biodegradable polymer segment is anticipated to witness growth at a CAGR of 7.5% over the forecast years, driven by the increasing demand for temporary stenting solutions that gradually degrade within the body after fulfilling their therapeutic function.
 

• The market share of nitinol veterinary stents has expanded due to the unique expansion capabilities of nitinol stents, which provide flexibility, excellent biocompatibility, and corrosion resistance, making it an ideal material for stents used in veterinary medicine.
   
• Stents constructed from nitinol are actively employed in the management of airway collapse, vascular blockages, and urinary tract disorders in animals, offering low-impact intervention while supporting long-term structural stability and adaptability to evolving anatomic shifts.
   
• The increasing adoption of self-expanding nitinol stents in veterinary practice has greatly enhanced growth in this market segment. Self-expanding stents optimize placement within the vessel and significantly reduce the possibility of movement or blockage due to scar tissue formation.
   
• In addition, increasing development of coated biodegradable nitinol stents, guided stent implantation methods, and precise placement improve treatment results and clinical outcomes, thus fostering the growth of this market segment.
   

Based on end use, the veterinary stents market is bifurcated into veterinary hospitals and clinics and other end users. The veterinary hospitals and clinics segment is expected to grow at 6.8% CAGR to reach USD 74.5 million by 2035.
 

• Veterinary hospitals and clinics are the primary points of care, providing diagnostic imaging, endoscopic operations, and minimally invasive surgeries such as stenting for the correction of tracheal collapse, urethral obstruction, and esophageal stricture.
   
• Access to advanced specialty veterinary services and stenting procedures provided by 24/7 emergency hospitals has improved significantly, resulting in increased market adoption.
   
• Additionally, the growing humanization of pets and rising pet ownership has led to an increase in expenditure on stenting solutions and other advanced surgical care.
   
• Furthermore, increased pet insurance coverage in developed regions such as North America and Europe propels the veterinary hospitals and clinics segment of the market, as costly procedures become widely accessible.

North America Veterinary Stents Market

The North America veterinary stents industry dominated the global market with a market share of 41.5% in 2025.
 

• The North America market holds a dominant share due to the region’s advanced veterinary healthcare infrastructure and high adoption of specialized treatment procedures for companion animals.
   
• The presence of a large number of veterinary specialty hospitals, referral centers, and well-established veterinary practices enables the widespread use of minimally invasive interventions such as stent placement.
   
• Furthermore, high pet healthcare expenditure and widespread availability of pet insurance in North America improve the affordability of complex procedures such as tracheal and ureteral stenting.
   
• The strong presence of key veterinary device manufacturers and continuous technological advancements in veterinary interventional devices further contribute to the region’s leadership in the market.
   

The U.S. veterinary stents market was valued at USD 15.4 million and USD 16.1 million in 2022 and 2023, respectively. In 2025, the market size reached USD 17.7 million, growing from USD 16.8 million in 2024.
 

• This growth is largely attributed to the high pet ownership levels and the well-developed veterinary care facilities in the country.
   
• According to the 2021–2022 National Pet Owners Survey by the American Pet Products Association (APPA), 70% of U.S. households owned at least one pet, including approximately 69 million dog-owning households, 45.3 million with cats, 9.9 million with birds, and 3.5 million with horses.
   
• This increased pet ownership has increased the demand for specialized veterinary services, which including stenting for tracheal collapse, urethral obstruction, and vascular conditions.
   
• Moreover, the U.S. is well known for having a developed system of veterinary pet hospitals, specialized clinics, and emergency centers, many of which are equipped to perform stent placement through imaging and endoscopic techniques.
   

Europe Veterinary Stents Market

The Europe veterinary stents industry accounts for a significant share of the global market, supported by the region’s well-established veterinary healthcare infrastructure and growing awareness of advanced treatment options for companion animals.
 

• Increasing pet ownership across major European countries such as Germany, the UK, France, and Italy has contributed to rising demand for specialized veterinary procedures.
   
• According to FEDIAF (European Pet Food Industry Federation), approximately 166 million cats and dogs were owned as pets across Europe in 2022, highlighting the large companion animal population requiring medical care.
   
• Additionally, the presence of advanced veterinary referral hospitals, increasing pet healthcare expenditure, and growing availability of pet insurance in countries such as the UK, Sweden, and Germany are supporting the adoption of minimally invasive procedures like stent placement.
   

Germany veterinary stents market is expected to witness significant growth in the Europe market over the analysis period.
 

• As one of the largest pet markets in Europe, Germany has a significant population of pet dogs and cats, which increases the demand for specialized veterinary treatments, including stent procedures for airway collapse, urethral obstructions, and vascular anomalies.
   
• Furthermore, favorable regulatory support for animal welfare and wide adoption of pet insurance coverage have encouraged pet owners to opt for advanced, costlier treatments to improve pet health outcomes.
   

Asia Pacific Veterinary Stents Market

The Asia Pacific veterinary stents industry is expected to experience significant growth over the forecast period.
 

• Rapid urbanization and changing lifestyles have led to increased adoption of companion animals, particularly in urban areas, which contributes to greater demand for advanced veterinary treatments.
   
• For example, in India, pet ownership has been growing rapidly, with the country’s pet population increasing from about 26 million in 2019 to around 42 million in 2024, reflecting strong growth in companion animal adoption.
   
• Additionally, improving veterinary healthcare infrastructure and the expansion of veterinary clinics and specialty hospitals are enabling the adoption of minimally invasive procedures such as stent implantation.
   
• Increasing disposable incomes and rising expenditure on pet healthcare are further supporting the demand for advanced veterinary medical devices in the region.
   

The China veterinary stents market dominates the Asia-Pacific market.
 

• According to the Chinese Pet Industry Association (2023), over 60% of urban households in China now own pets, a substantial increase from 48% in 2021. This sharp rise indicates a shift in attitudes among younger people, as many now consider pets part of the family and tend to spend more on their health and well-being.
   
• There is an increased pet patient population, which in turn increases the demand for veterinary services that offer specialized care. These types of care include minimally invasive procedures such as stenting for tracheal collapse, urinary tract obstruction, and vascular anomalies.
   

Latin America Veterinary Stents Market

Brazil veterinary stents market is experiencing significant growth in the Latin America market.
 

• With approximately 168 million pets, Brazil holds the third-largest pet population in the world and the largest in Latin America, where dogs are the most common companion animals.
   
• The rise in the humanization of pets, where pets are increasingly treated as family members, has positively impacted the increased spending on veterinary services, including those requiring veterinary stents.
   
• This market is growing due to strong focus and increasing awareness of severe conditions such as tracheal collapse, urethral obstruction, and esophageal strictures.
   

Middle East and Africa Veterinary Stents Market

Saudi Arabia veterinary stents market is poised to witness rapid growth in the Middle East and Africa market.
 

• The country has seen a notable shift in attitudes toward pet ownership, particularly among younger generations and urban populations, where dogs and cats are becoming increasingly popular as companion animals.
   
• This shift is translating into greater demand for specialized veterinary care, including the use of stents for treating airway collapse, urinary tract obstructions, and vascular disorders in animals.
   
• In addition, the emergence of private veterinary service providers, rising disposable income, and increased awareness of companion animal health are further accelerating market growth.
   

Veterinary Stents Market Share

The veterinary stents industry is moderately consolidated, with established companies and emerging innovators competing on product portfolios, geographic coverage, and areas of expertise. The top 3 players, Infiniti Medical, Dextronix, and TaeWoong Medical, accounted for approximately 35% of the global market, owing to their extensive veterinary-specific stent portfolios. Infiniti Medical is recognized for its wide range of products, including stents for the trachea, urethra, and vessels, and for its product line, alongside its commitment to clinician training and procedural support, positioning it as a leader in the segment.
 

These companies provide customized designs for conditions such as airway collapse in small-breed dogs, enabling them to serve niche segments that are often neglected. As the demand for minimally invasive veterinary procedures continues to grow, competitive dynamics are expected to intensify, with innovation, training, and regional expansion being the key differentiators.
 

Veterinary Stents Market Companies

Some of the prominent players operating in the veterinary stents industry include:

• AbtVet (Stening group)
• Create Medic
• Dextronix
• EpiicVet
• Infiniti Medical
• M.I. Tech
• TaeWoong Medical
• UltraVet Medical Devices
   
• Infiniti Medical

Infiniti Medical has an extensive and diversified veterinary stent portfolio, including Vet Stent-Trachea, Ureter, Urethra, and Cava, and a global distribution network, widely recognized for technological innovation and training support.
 

• Create Medic

Create Medic is known for its high-precision urethral and urinary stents and benefits from a strong foothold in Asia, particularly Japan, and a focus on urological innovations for both human and veterinary use.
 

Veterinary Stents Industry News

• In October 2024, Infiniti Medical expanded its Vet Stent Cava portfolio by introducing two new product variants with diameters of 28 mm and 30 mm. This strategic product expansion enabled the company to cater to a broader range of veterinary patients, enhancing its market presence and meeting the growing demand for size-specific stent solutions in companion animals.
   
• In November 2024, veterinarians from Linnaeus Veterinary Limited, UK, partnered with The British Veterinary Clinic in the UAE to successfully perform the country's first veterinary interventional cardiology procedures, including stenting and balloon valvuloplasty. This strategic collaboration is driving market growth by expanding access to advanced veterinary procedures in emerging regions and boosting demand for specialized stenting solutions.
   
• In December 2023, Neuromed, a division of Infiniti Medical, in collaboration with a team of seven veterinary and human medicine experts, recently performed a complex spine and pelvic surgery on Chelsea, a 9-month-old Great Pyrenees with severe back problems. The procedure, which included a bone graft infused with antibiotics, is expected to alleviate her pain and improve her chances of adoption. This case highlights the growing demand for advanced veterinary stent solutions, driven by the need for innovative treatments to address complex conditions in animals.
   

The veterinary stents market research report includes in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2022 - 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Airway stents
• Vascular stents
• Urethral stents
• Other stents

Market, By Animal

• Dogs
• Cats
• Other animals

Market, By Application

• Airway collapse
• Vascular obstructions
• Urinary tract obstructions
• Other applications

Market, By Material

• Nitinol
• Biodegradable polymer

Market, By End Use

• Veterinary hospitals and clinics
• Other end users
   

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina

• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE